Summary
This position paper by Cefic discusses the importance of Human Biomonitoring (HBM) in assessing chemical exposure in both workers and the general population. HBM involves analysing human samples (e.g., blood, urine) to measure chemical exposure, although it cannot directly determine health effects. The European chemical industry, supportive of HBM4EU initiatives, emphasises that HBM studies should use validated analytical methods and be conducted by qualified labs to ensure reliable results. Proper communication of HBM results is also crucial. By comparing exposure concentrations to scientifically derived guidance values and considering exposure sources, HBM can help evaluate potential health risks.
Key Takeaways:
- Validated and harmonised analytical methods are essential for reliable HBM studies and should be conducted by qualified laboratories.
- Health-based guidance values and contextual exposure information are critical to assess the potential health risks of measured chemical exposures.
- Clear, fact-based communication of HBM results is key, requiring involvement from multidisciplinary experts to ensure balanced and objective dissemination.
